Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 76, pseudogene (RNU6-76P) is a processed pseudogene in the human genome, with sequence similarity to the functional U6 small nuclear RNA (snRNA). It has no protein-coding potential and is generally considered non-functional. While the functional U6 snRNA is a vital component of the spliceosome—the cellular machinery responsible for removing introns from pre-mRNA—the pseudogene variant does not participate in splicing or have a known biological role. The human genome contains multiple copies and pseudogenes of U6 snRNA, resulting from retrotransposition events involving LINE elements[3][7]. Such pseudogenes are common and serve as evolutionary markers but do not encode functional RNAs or proteins[2][6][8]. If you require structured information on the functional U6 snRNA molecule—involved in pre-mRNA splicing and important for gene expression regulation—please clarify, as *RNU6-76P* is not itself an active therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 76, pseudogene (RNU6-76P).